CellWell record HH-544270
Exploring the impact of melatonin on cancer-related fatigue: a dose-response meta-analysis with GRADE evidence evaluation
Sajjad Etesamnia; Mahdiyar Nasiraie-Moghadam; Pariya Mostafazadeh; Mohammad-Reza Jowshan; Kamran Roudini; Seyed Rohollah Miri; Alireza Jahan-Mihan; Alireza Haghighi; Soraiya Ebrahimpour-Koujan
2026
In plain language
Meta-analysis of 12 randomized placebo-controlled trials (1,977 cancer patients) found melatonin was associated with reduced fatigue, with greater benefit at 5-15 mg/day and short-term use.
- Evidence
- Established
- Design
- Meta-analysis
Cite this record: https://thecellwell.org/studies/HH-544270
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.